BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 11715280)

  • 1. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP; Wakade A; Antia NH
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinguishing between relapse and late reversal reaction in multidrug (MDT)-treated BT leprosy.
    Waters MF
    Lepr Rev; 2001 Sep; 72(3):250-3. PubMed ID: 11715270
    [No Abstract]   [Full Text] [Related]  

  • 3. Generalized annular borderline tuberculoid leprosy and update in management of Hansen's disease.
    Young RJ; Gilson RT; Elston DM
    Cutis; 2000 Apr; 65(4):203-6. PubMed ID: 10795079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients" by Shetty et al.
    Desikan KV
    Lepr Rev; 2002 Sep; 73(3):282. PubMed ID: 12449896
    [No Abstract]   [Full Text] [Related]  

  • 5. Leprosy in HIV infection: a study of three cases.
    Rath N; Kar HK
    Indian J Lepr; 2003; 75(4):355-9. PubMed ID: 15242274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline tuberculoid leprosy localised over a scar.
    Kar BK; Job CK
    Indian J Lepr; 2005; 77(2):173-6. PubMed ID: 16044818
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA; Mearag I; Saleh NM; Saied A
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of mycobacterium leprae from untreated borderline tuberculoid, mid-borderline and indeterminate cases using the mouse foot pad technique--a study of 209 cases.
    Wakade AV; Shetty VP
    Lepr Rev; 2006 Dec; 77(4):366-70. PubMed ID: 17343223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
    Kumar A; Girdhar A; Girdhar BK
    Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems of multidrug therapy.
    Ramu G
    Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
    [No Abstract]   [Full Text] [Related]  

  • 15. Viability and drug susceptibility testing of M. leprae using mouse footpad in 37 relapse cases of leprosy.
    Shetty VP; Wakade AV; Ghate S; Pai VV; Ganapati R; Antia NH
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):210-7. PubMed ID: 14608816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
    Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
    Suneetha S; Reddy R
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):53-4. PubMed ID: 11480321
    [No Abstract]   [Full Text] [Related]  

  • 18. Skin smear examination in paucibacillary leprosy patients.
    Bhatia VN
    Indian J Lepr; 1991; 63(2):209-12. PubMed ID: 1783789
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study.
    Revankar CR; Karjivkar VG; Gurav VJ; Ganapati R
    Indian J Lepr; 1989 Jul; 61(3):355-9. PubMed ID: 2768883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leprosy in five human immunodeficiency virus-infected patients.
    Moran CA; Nelson AM; Tuur SM; Luengu M; Fonseca L; Meyers WM
    Mod Pathol; 1995 Aug; 8(6):662-4. PubMed ID: 8532702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.